I-123 metaiodobenzylguanidine innervation imaging as a tool for norepinephrine transporter research: A possible application for genetic analysis in heart failure-Reference-Cited by-同舟云学术

I-123 metaiodobenzylguanidine innervation imaging as a tool for norepinephrine transporter research: A possible application for genetic analysis in heart failure

Published:2016-11-28 Issue:3 Volume:25 Page:907-910
ISSN:1071-3581
Container-title:Journal of Nuclear Cardiology
language:en
Short-container-title:J. Nucl. Cardiol.

Author:

Nakajima Kenichi,Matsunari Ichiro,Jacobson Arnold F.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Link

http://link.springer.com/article/10.1007/s12350-016-0739-1/fulltext.html

Reference24 articles.

1. Matsunari I, Aoki H, Nomura Y, Takeda N, Chen WP, Taki J, et al. Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction. Circ Cardiovasc Imaging. 2010;3:595–603.

2. Thackeray JT, Bengel FM. Assessment of cardiac autonomic neuronal function using PET imaging. J Nucl Cardiol. 2013;20:150–65.

3. Delforge J, Syrota A, Lancon JP, Nakajima K, Loc’h C, Janier M, et al. Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method. J Nucl Med. 1991;32:739–48.

4. Rami-Mark C, Berroteran-Infante N, Philippe C, Foltin S, Vraka C, Hoepping A, et al. Radiosynthesis and first preclinical evaluation of the novel norepinephrine transporter pet-ligand [11C]ME@HAPTHI. EJNMMI Res. 2015;5:113.

5. Verschure DO, Baas F, van Eck-Smit BLF, Somsen GA, Verberne HJ. Polymorphism of SLC6A2 gene does not influence outcome of myocardial 123I-mIBG scintigraphy in patients with chronic heart failure. J Nucl Cardiol. 2016. doi: 10.1007/s12350-016-0722-x .